The Gross Margin of BioNexus Gene Lab Corp (BGLC) is 13.56%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 13.56% |
| 2023-12-31 | 13.62% |
| 2022-12-31 | 11.53% |
| 2021-12-31 | 16.92% |
| 2020-12-31 | 15.10% |
| 2019-12-31 | 46.15% |
| 2018-12-31 | 14.29% |
| 2017-12-31 | 72.73% |